4//SEC Filing
PROVECTUS BIOPHARMACEUTICALS, INC. 4
Accession 0001140361-15-000969
$PVCTCIK 0000315545operating
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 3:29 PM ET
Size
11.4 KB
Accession
0001140361-15-000969
Insider Transaction Report
Form 4
CULPEPPER PETER R
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2015-01-07$0.75/sh+33,334$25,001→ 154,334 total(indirect: By 401(k)) - Exercise/Conversion
Common Stock
2015-01-07$0.94/sh+29,786$27,999→ 184,120 total(indirect: By 401(k)) - Exercise/Conversion
Stock Option (right to buy)
2015-01-07−33,334→ 0 totalExercise: $0.75Exp: 2015-05-25→ Common Stock (33,334 underlying) - Exercise/Conversion
Stock Option (right to buy)
2015-01-07−29,786→ 145,214 totalExercise: $0.94Exp: 2015-12-09→ Common Stock (29,786 underlying)
Holdings
- 1,112,332
Common Stock
Footnotes (2)
- [F1]The option became exercisable in three equal annual installments beginning on May 26, 2006.
- [F2]The option became exercisable in three equal annual installments beginning on December 9, 2006.
Documents
Issuer
PROVECTUS BIOPHARMACEUTICALS, INC.
CIK 0000315545
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000315545
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 3:29 PM ET
- Size
- 11.4 KB